Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-04-22

Clinical Trial Update: Efficacy of Subcutaneous Injection of Etanercept for Moderate and Severe Knee Osteoarthritis [NA]

View source ↗

Summary

Clinical trial update on the efficacy of subcutaneous etanercept for moderate to severe knee osteoarthritis. Current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ENBREL (etanercept)

Snippet

Sponsor: First Affiliated Hospital of Harbin Medical University | Conditions: Osteoarthritis Of Knee | NA | Status: UNKNOWN